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Age-Related Differences in Sensitivity of Peripheral
Blood Monocytes to Lipopolysaccharide and
Staphylococcus Aureus Toxin B in Atopic Dermatitis
Marie Mandron1, Marie-Franc¸oise Arie`s2, Franck Boralevi1,3, He´le`ne Martin1, Marie Charveron2,
Alain Taieb4,5 and Christian Davrinche1
As shown by atopy patch tests, atopic dermatitis (AD) is dominated in its acute phase by the development of a
specific TH2 response after exposure of the skin to common environmental antigens. Relying on our previous
data showing that Staphylococcus aureus enterotoxin B (SEB) induced the activation of monocyte-derived
dendritic cells (DCs) through Toll-like receptor (TLR)2 and that SEB-pulsed DCs commit allogenic naive T cells
into TH2, we assessed monocytes sensitivity to SEB and lipopolysaccharide (LPS) in a group of children and adult
patients with AD. Monocytes from AD patients (15 adults with mostly severe disease and 15 children with mild
to moderate disease) exhibited an activated and tolerant state as supported by (i) secretion of large amounts of
IL-6, IL-10, and tumor necrosis factor-a even in the absence of stimulation; (ii) their inability to modulate neither
HLA-DR and CD54 nor TLR2 and TLR4 expression after in vitro challenge with SEB; (iii) inhibition of IL-12p70
secretion in response to LPS. Interestingly, monocytes from some of the children studied responded to in vitro
challenge with LPS, suggesting new hypotheses to explain disease regression. Our data support the notion that
monitoring sensitivity of monocytes to bacterial toxins could prove useful to assess disease progression and
prognosis in AD.
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INTRODUCTION
Atopic dermatitis (AD) is a chronic inflammatory skin disease
characterized by typically distributed pruritic eczematous
skin lesions associated with an hyper-reactivity to environ-
mental triggers (Darsow et al., 2005). The pathophysiology of
AD results from a complex interaction of genetics, environ-
mental, and immunological factors, and current research
focuses on the interactions between an intrinsically abnormal
cutaneous permeability barrier (Taieb, 1999) and the innate
immune system (McGirt and Beck, 2006). Especially, the
initial maturation steps of the skin barrier in the first months
of life are viewed as pivotal to induce a skin-borne skewing
of the immune system toward TH2 responses (Taieb et al.,
2006). Besides an increased proneness to react to irritants
and to enhance the penetration of allergens, the overall
impairment of cutaneous barrier function noted in AD leads
to an increased susceptibility to herpes simplex virus and is
associated with a colonization by Staphylococcus aureus,
detected in more than 90% of patients in non-eczematous
skin, both events being associated with a decreased produc-
tion of antimicrobial peptides (Leung et al., 1993; Ong et al.,
2002; Howell et al., 2006). More than half of S. aureus strains
isolated from AD patients are able to produce exotoxins with
superantigenic activity such as staphylococcal enterotoxin A,
S. aureus enterotoxin B (SEB), or toxic shock syndrome
toxin-1 (Hoeger et al., 1992). All of these toxins can mediate
nonspecific T-cell activation by their superantigenic activity
and act as conventional allergens stimulating the production
of specific antibodies (McFadden et al., 1993). In some
patients, specific IgE antibodies directed against staphylo-
coccal superantigens have been detected in both sera and
skin (Leung et al., 1993) that could lead to the release of
histamine from basophils and also induce the activation of
antigen-presenting cells bearing specific receptors. Interes-
tingly, it has been reported that serum levels of antibodies
directed against staphylococcal toxin correlate with disease
severity (Zollner et al., 2000).
Professional antigen-presenting cells such as dendritic
cells (DCs) and monocyte–macrophages are activated
through recognition of pathogen-derived molecular patterns
ORIGINAL ARTICLE
882 Journal of Investigative Dermatology (2008), Volume 128 & 2007 The Society for Investigative Dermatology
Received 24 January 2007; revised 9 July 2007; accepted 15 August 2007;
published online 25 October 2007
1INSERM, U563, Centre de Physiopathologie de Toulouse Purpan, Toulouse,
France; 2Centre de Recherche Pierre Fabre CERPER, Toulouse, France; 3Unite´
de dermatologie pe´diatrique, Hoˆpital Pellegrin-Enfants, Universite´ de
Bordeaux 2–Victor Segalen, Bordeaux, France; 4Service de dermatologie et
Unite´ de dermatologie pe´diatrique, Hoˆpitaux St Andre´ et Pellegrin-Enfants,
CHU de Bordeaux, Bordeaux, France and 5INSERM E217, Universite´
Bordeaux 2–Victor Segalen, Bordeaux, France
Correspondence: Dr Christian Davrinche, INSERM, U563, Centre de
Physiopathologie de Toulouse Purpan, Toulouse F-31300, France.
E-mail: davrinch@toulouse.inserm.fr
Abbreviations: AD, atopic dermatitis; DC, dendritic cell
LPS, lipopolysaccharide; MFI, mean fluorescence intensity; NK, natural killer;
SEB, Staphylococcus aureus enterotoxin B; TLR, Toll-like receptor
by innate receptors such as Toll-like receptors (TLRs). Sensing
of pathogens by activated monocytes known to express most
of the TLRs (Kadowaki et al., 2001) takes part in the
development of an adaptive immunity and also permits to
control dissemination of infection by inducing local inflam-
mation. Besides recognition of the known bacterial pathogen-
derived molecular patterns by TLR, we speculated that cells
of the monocyte–macrophage lineage as well as DCs could
sense toxins such as those secreted by S. aureus and then
contribute to an early control of infection. In a previous work,
we demonstrated that SEB could induce the maturation of
DCs through activation of TLR2 leading to priming of naive
allogenic T cells into TH2 (Mandron et al., 2006), a finding
which may pertain to the sequence of events noted in the skin
in early AD natural history, since staphylococci found at the
skin surface could induce, through toxin production, a signal
affecting T-cell commitment.
Our hypothesis, in this study, was that the maturation
of SEB-driven innate immune responses could reflect
eventually the course and severity of AD. We first show
that TLRs can participate to the activation of normal
monocytes by SEB, as already shown for monocyte-derived
DCs (Mandron et al., 2006). We further provide evidence
that, contrary to non-atopic controls, most AD adult
patients and a majority of children show an hyperactivated
status of their purified monocytes that release spontaneously
large amounts of inflammatory cytokines (IL-6, IL-10,
and tumor necrosis factor (TNF-a)) but fail to respond
to an additional stimulation with SEB. However, we
could detect that hyporesponsiveness of AD monocytes to
lipopolysaccharide (LPS), as revealed by the absence of
bioactive IL-12 (IL-12p70) secretion, was sparing some AD
children, and this finding may reflect an essential step in
disease progression.
RESULTS
SEB can activate normal human monocytes
To analyze the effect of SEB on human monocytes, peripheral
blood monocytes were isolated by magnetic cell sorting using
CD14þ -positive selection and incubated with increasing
concentrations of SEB or LPS (1–1,000 ngml1) for 24 hours.
Cells were then analyzed for surface expression of HLA-DR
by flow cytometry (Figure 1a). Figure 1b shows that HLA-DR
expression increased with respect to SEB concentration and
that a twofold increase of mean fluorescence intensity (MFI)
was obtained with as less as 1 ngml1 of toxin. Similar results
were obtained when using highly purified SEB (data not
shown). In contrast, LPS induced a quite low increase of HLA-
DR expression. SEB and LPS were used at 10 ngml1 final
concentration for subsequent investigations. We then ana-
lyzed the expression of various markers known to reflect
activation of monocytes such as CD54, CD80, and CD86.
After treatment with SEB or LPS, a strong upregulation of
CD54 and CD80 expression was observed under stimulation
with either SEB or LPS (Figure 2) contrasting with a slight
inhibition of CD86 expression. These data demonstrated that
like LPS, SEB was able to induce activation of human
monocytes.
SEB-mediated activation of normal monocytes induces
modulation of TLR expression
It is well known that binding of LPS to TLR4 induces
activation of inflammatory cells of the monocyte–macro-
phage lineage, including DCs. We already demonstrated that
normal monocyte-derived DCs were able to secrete TNF-a in
response to interaction of SEB with TLR2 (Mandron et al.,
2006). Moreover, we showed that SEB induced activation of
NF-kB in stably transfected TLR2-HEK293 cells, which do not
express MHC (major histocompatibility complex) class II,
confirming the ability of SEB to trigger TLR2 signaling.
To investigate whether TLRs could participate in the
activation of normal monocytes by SEB, we analyzed TLR2
and TLR4 expression on cells after stimulation with increas-
ing doses of toxin. Cytometric analysis of TLR2 and TLR4
protein expression at the surface of untreated monocytes
revealed a constitutive expression of both receptors. Treat-
ment with SEB induced a significant upregulation of TLR2
and TLR4 expression even at low SEB concentration
(10 ngml1) (Figure 3a). To clarify the role of TLR2 and
TLR4 in SEB-induced activation of monocytes, cells were
pretreated with neutralizing antibodies against TLR2 or TLR4
before SEB or LPS stimulation and analyzed for TNF-a
secretion. Figure 3b shows that after 24 hours of stimulation,
SEB-treated monocytes were able to produce TNF-a and at a
higher level than those treated with LPS. When monocytes
were pretreated with either anti-TLR2 or anti-TLR4 neutraliz-
ing antibodies before incubation with SEB, a significant
decrease in TNF-a secretion was observed. As we expected,
TNF-a secretion following stimulation with LPS was abo-
lished only in the presence of TLR4 neutralizing antibody.
When both anti-TLR antibodies were used, as well as when
anti-MHC class II antibodies were added to the mixture, no
extra neutralization was observed. This may be explained for
instance by (i) saturation of MyD88 or TRAF6 recruitment
when any of the TLR2 or TLR4 is triggered and (ii) the absence
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Figure 1. Activation of CD14þ monocytes by SEB. (a) Monocytes
isolated from non-atopic subjects were treated with increasing concentration
of SEB or LPS (0–1,000 ngml1). After 24 hours of incubation, HLA-DR
expression was analyzed by flow cytometry, and histograms of MFI are
shown. (b) Graphic representation of dose–response to stimulations with SEB
or LPS. Averages from all the patients tested with standard deviations are
shown.
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of TNF-a secretion through MHC class II in conditions used in
our experiments (low SEB concentrationy). These results
suggested that interaction of SEB with both TLR2 and TLR4
could lead to monocyte activation as revealed by both
upregulation of activation markers and secretion of TNF-a.
Monocytes from AD patients are hyperactivated and
desensitized to SEB stimulation
In non-atopic individuals, colonization of the epidermis by
S. aureus is controlled by cutaneous immunity, and we can
speculate that in atopic patients with high colonization the
early recognition of pathogens by sentinel cells such as
monocytes and DCs could be impaired. Assuming a role for
monocytes or monocyte-derived cells in sensing S. aureus,
we asked whether variations in sensitivity of atopic patients to
S. aureus toxins could reflect those dysfunctions. Sensitivity
to stimulation with SEB or LPS (10 ngml1) of monocytes
isolated from 30 AD patients was compared with that of
monocytes from 15 non-atopic controls, as assessed by flow
cytometry analysis of HLA-DR expression.
Figure 4 shows a strongly significant (Po0.001) upregula-
tion of HLA-DR on monocytes of non-atopic individuals after
treatment with SEB, contrasting with a barely detectable
modulation on those from AD patients (P40.05). Further-
more, we observed a stronger constitutive expression of HLA-
DR on monocytes from atopic children than on those from
non-atopic adult. This may reflect an activated stage of
monocytes from AD patients, which is likely due to their
inflammatory status. To assess whether upregulation of HLA-
DR on NAD (non-atopic dermatitis) monocytes could depend
on the presence of IFN-g secreted by contaminating activated
T cells in the monocyte preparation, cocultures of monocytes
(Mo) with autologous T cells (T) were performed at T to Mo
ratios ranging from 0.01 to 1. Cocultures were treated with
SEB (10 ngml1) for 24 hours and IFN-g was quantified by
ELISA. At T to Mo ratios from 0 to 0.1, the average amounts
(five independent experiments) of secreted IFN-g ranged
from 50 to 3,500 pgml1, respectively, and reached
20,000 pgml1 at 1:1 ratio (data not shown). Then, equiva-
lent amounts of recombinant IFN-g were added to purified
monocytes in the absence of SEB, and HLA-DR expression
was analyzed by flow cytometry. In these conditions, no
upregulation of HLA-DR expression was observed except at
the highest amount of IFN-g used but in a low percentage of
cells, demonstrating that upregulation of HLA-DR by SEB was
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Figure 2. Phenotype of SEB-activated monocytes. Monocytes were cultured in the presence of 10 ngml1 of SEB or LPS or left untreated (NT) for 24 hours.
HLA-DR, CD54, CD80, and CD86 surface expression was analyzed by flow cytometry as described in the Materials and Methods section.
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Figure 3. Modulation of TLR2 and TLR4 expression on activated
monocytes. (a) Monocytes were either untreated (NT) or incubated for
24 hours with 10 ngml1 of SEB or LPS. Surface expression of TLR2 and
TLR4 was analyzed by flow cytometry, and histograms of MFI are shown.
(b) Monocytes were preincubated with neutralizing antibodies to TLR2 or
TLR4 or isotypic control. Cells were treated for 24 hours with 10 ngml1
of SEB or LPS, and TNF-a secretion was analyzed by ELISA on culture
supernatants.
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not due to contaminating T cells, which never represented
more than 1% of monocyte preparations.
As shown by cytokine production, AD monocytes are
hyperactivated and cannot respond to an additional in vitro
stimulation with SEB
Activation of monocytes leads to the secretion of cytokines
that are important for the control of pathogen colonization
and the development of appropriate immune responses. We
used a cytometry bead array assay to investigate secretion of
inflammatory cytokines by monocytes either untreated
or incubated with SEB or LPS. Monocytes isolated from
non-atopic individuals (NADs, Figure 5) secreted the
inflammatory cytokines IL-6 and TNF-a and the regulatory
cytokine IL-10 under treatment with SEB but at a lower level
than those from atopic patients (ADs), suggesting that AD
monocytes have been activated in vivo and could not
respond to an additional in vitro stimulation with SEB.
TLR expression on monocytes is not modulated by SEB in AD
patients
Then, we analyzed the expression of TLR2 and TLR4 after
stimulation of monocytes with SEB or LPS (10 ngml1 for
24 hours), by flow cytometry. Figure 6 shows that expression
of TLR2 on AD monocytes was unchanged after exposure to
SEB in contrast with a strong upregulation in non-atopic
subjects (Po0.001). Similarly, TLR4 expression was not
enhanced after exposure to SEB.
Age-related differential production of IL-12 by monocytes
isolated from AD patients in response to LPS
IL-12p70 secretion is a crucial factor in the establishment of
immunity against pathogens because it drives the develop-
ment of TH1 responses. In a previous study, we demonstrated
that mature DCs were not able to produce IL-12p70 in
response to stimulation with SEB and committed naive
allogenic T cells into TH2 (Mandron et al., 2006). Accord-
ingly, we asked whether monocytes from AD patients were
able to secrete bioactive IL-12 in response to LPS and SEB.
Secretion of IL-12p70 was quantified by ELISA on non-atopic
monocytes and compared with that from AD patients. As
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Figure 4. Activation of monocytes from atopic (AD) patients. Monocytes from 30 AD patients (15 adults and 15 children) or 15 non-atopic controls as
indicated were cultured for 24 hours in the presence of 10 ngml1 of SEB or LPS. Surface expression of HLA-DR was analyzed by flow cytometry, and histograms
of MFI values are shown after deduction of MFI values corresponding to isotypic controls. Mean values of MFI for each experiment are artificially connected
and compared according to paired Student’s t-test (*Po0.005, **Po0.001, NS, not significant).
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Figure 5. Production of cytokines by atopic monocytes. Monocytes
isolated from AD patients and non-atopic controls were treated with
10 ngml1 of SEB or LPS. Supernatants collected after 24 hours of incubation
were analyzed for cytokine production using cytometry bead array assay.
Histograms show concentration (pgml1) for IL-6, IL-10, and TNF-a cytokines
secreted by monocytes from 10 different adult individuals either non-atopic
(NAD) or atopic (AD).
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expected, stimulation of monocytes from non-atopic subjects
with LPS induced IL-12p70 secretion (Figure 7). On the
opposite, no IL-12p70 secretion was observed after stimula-
tion of these cells with SEB confirming our previous results
obtained on DCs (Mandron et al., 2006).
We then determined the ability of monocytes from adult
patients to produce the bioactive form of IL-12. Neither
untreated nor SEB-treated adult AD monocytes produced
significant levels of IL-12p70 as observed in non-atopic
subjects. Interestingly, under stimulation with LPS, IL-12p70
production was significantly lower in AD monocytes than in
non-atopic controls.
We next analyzed the capacity of monocytes from AD
children to secrete IL-12p70. Similarly to monocytes isolated
from non-atopic subjects or adult atopic patients, untreated
as well as SEB-treated monocytes isolated from atopic
children did not produce significant amounts of IL-12p70.
Nevertheless, contrary to adult patients, some of the children
examined in this study (inset in Figure 7) were able to respond
to LPS stimulation and produced amounts of IL-12 within the
same range as that observed in non-atopic adult individuals.
DISCUSSION
Skin colonization by S. aureus is a key factor in
the pathogenesis of AD, in spite of the limited therapeutic
impact of anti-staphylococcal intervention in established
disease. One of the strategies whereby S. aureus exacerbates
AD is by secreting toxins able to stimulate lymphocytes through
their superantigenic activity, thus creating strong inflammatory
conditions leading to an increased bacterial colonization of skin.
Besides their known superantigenic effects on T lympho-
cytes, we assumed that owing to their ability to gain access to
epidermal monocytes and DCs, exotoxins could take part in
the early steps of the disease in local inflammation of still
undamaged skin. Assuming that interactions of toxins with
monocytes could result in secretion of cytokines leading to an
inappropriately biased response of T lymphocytes, mono-
cytes from non-atopic subjects and AD patients were isolated
from peripheral blood using magnetic cell sorting and
incubated with SEB or LPS. Then, according to our previous
data demonstrating a role for TLR2 in activation of DCs by
SEB, we analyzed the capacity of SEB to induce activation of
monocyte and to modulate TLR2 and TLR4 expression. In this
report, we demonstrate that in non-atopic subjects activation
of monocytes with SEB resulted in an upregulation of HLA-
DR, CD80, and CD54. Analysis of TLR expression revealed a
strong constitutive expression of both TLR2 and TLR4 that
was upregulated after exposure to SEB. Secretion of TNF-a
was partly but significantly blocked when cells were
pretreated with TLR2 and TLR4 neutralizing antibodies,
demonstrating a key role for SEB-mediated signaling of TLR
in activation of monocytes. Regarding the absence of DCs
activation by SEB through TLR4 in our previous study
(Mandron et al., 2006), we can assume that it was due to a
lower expression of TLR4 and CD14 on monocytes-derived
DCs than on monocytes. Monocytes isolated from atopic
patients were constitutively activated and resisted to sub-
sequent in vitro stimulation as assessed through analysis of
both activation markers and cytokines secretion. Accord-
ingly, stimulation of monocytes from AD patients with SEB
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Figure 6. Modulation of TLR2 and TLR4 expression on atopic monocytes. Cultures of monocytes from 30 AD patients or 15 non-atopic controls were
either untreated (NT) or cultured in the presence of 10 ngml1 of SEB or LPS for 24 hours. Surface expression of TLR2 and TLR4 was analyzed by flow cytometry
using specific monoclonal antibodies. Histograms of MFI values are shown after deduction of MFI values corresponding to isotypic controls. Mean values of
MFI for each experiment are artificially connected and compared according to paired Student’s t-test (**Po0.001, NS, not significant).
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did not modulate expression of TLR2 and TLR4 at their
surface.
TLR stimulation is crucial for activation of innate immunity
and for the control of an appropriate adaptive response
devoted to pathogen elimination. This study demonstrating
that both TLR2 and TLR4 can be involved in recognition of
SEB invites us to consider kinetics and outcomes of TLR
activation with respect to progression and severity of AD.
This assumption is supported by a previous report demon-
strating a decreased expression of many antimicrobial gene
products, including human b-defensin-3, TNF-a, and IFN-g in
AD skins, providing an explanation for their increased
susceptibility to microorganisms (Nomura et al., 2003), and
by studies demonstrating a predictive risk for subsequent AD
development in children with specific patterns of respon-
siveness by cord blood monocytes to SEB (Sharp et al., 2003).
Our observation that monocytes from AD patients are
desensitized to activation by LPS is in agreement with the
reported endotoxin tolerance in human and mice (Nomura
et al., 2000; Wysocka et al., 2001) as characterized by IL-12
suppression. Indeed, we can speculate that in vivo activation
of AD monocytes by SEB could make them refractory to
in vitro restimulation. Endotoxin tolerance in mouse macro-
phages was shown to partly correlate with downregulation of
TLR4 expression (Nomura et al., 2000). Moreover, an
association of endotoxin hyporesponsiveness with TLR4
mutations and of a polymorphism in TLR2 gene with
staphylococcal infection have been described in human
(Arbour et al., 2000; Lorenz et al., 2000). Interestingly, this
TLR2 missense mutation was shown to be associated with a
subgroup of AD patients with an increased disease severity
(Ahmad-Nejad et al., 2004), suggesting a critical role of TLR2
and TLR4 in SEB recognition with respect to clinically
relevant polymorphisms.
In the early steps of S. aureus infection, skin is not yet
damaged by local inflammation, and exotoxins could more
easily than the whole bacteria reach epidermal and dermal
target cells expressing the appropriate TLR, as supported by
detection of SEB in the dermis after epicutaneous application
(Skov et al., 2000). These first actors of innate sensing could
include keratinocytes that constitutively express TLR2 but no
TLR4 (Kollish et al., 2005), epidermal Langerhans cells, and
dermal DCs. We can make the assumption that interactions
between SEB and TLR on those various cell types may
specifically contribute to disease progression.
Finally, we observed significant differences in IL-12p70
secretion between monocytes from AD and non-atopic
individuals in response to stimulation with LPS, as previously
reported (Arbour et al., 2000, Aiba et al., 2003). Interestingly,
our study showed differences between children and adult
patients, since monocytes from some of the children tested
produced the bioactive form of IL-12 after treatment with LPS.
We could make the hypothesis that in these children,
monocytes hyporesponsiveness was abrogated for reasons
that remain to be determined but which could include a
better ability to control S. aureus infection, due for instance to
a protective TLR phenotype. Molecular mechanisms for
endotoxin tolerance are not fully elucidated but could
include reduction in TLR expression as well as modulation
of intracellular signaling. Interestingly, synergy and cross-
tolerance between TLR2 and TLR4 signaling have been
described (Sato et al., 2000), which could have sense in AD
progression with respect to the ability of SEB to interact with
both TLR.
Recovery of cell capacity to produce IL-12 upon
inflammatory conditions could provide new clues to explain
spontaneous disease regression in some children, whereas
lack of this cytokine could favor disease persistence in adults.
Besides the well-known evidence that impaired recogni-
tion of S. aureus cell wall components by TLR2 may
contribute to the pathogenesis of AD (Sato et al., 2000), this
report provides new insights into how bacterial toxins could
take part in this process. Furthermore, a possible recognition
of toxins by TLR2 and TLR4 on keratinocytes provides new
clue on how colonization by S. aureus could impair
expression of antimicrobial peptides such as human
b-defensin-2. Finally, since the development of TH1 or TH2
response may be controlled by TLRs activation, blocking the
binding of S. aureus toxins to these receptors could be
considered as a new therapeutic approach.
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Figure 7. Production of IL-12 by atopic monocytes.Monocytes isolated from
30 AD patients (15 adults and 15 children) and 15 non-atopic controls were
either untreated (NT) or treated with 10 ngml1 of SEB or LPS for 24 hours.
Secretion of IL-12p70 was subsequently analyzed by ELISA on culture
supernatants and compared according to paired Student’s t-test.
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MATERIALS AND METHODS
Donors
After informed consent, 30 patients with moderate to severe AD,
aged from 6 month to 54 years, were enrolled (15 children under 14
years of age and 15 adults). Fifteen non-atopic adults were recruited
as control. Disease severity was assessed using the SCORAD
cumulative index (Anonymous, 1993). The study was approved by
the Hospital Ethical Committee. The study was conducted according
to the Declaration of Helsinki Principles.
Selection of CD14þ monocytes
Peripheral blood mononuclear cells from non-atopic or atopic
individuals were isolated by standard density-gradient centrifugation
with Ficoll–Paque (Amersham Pharmacia Biotech, GE Healthcare
Europe GmbH, Orsay France) from 5ml of heparinized blood.
CD14þ monocytes were isolated by magnetic cell sorting using
positive selection with CD14þ microbeads (Miltenyi Biotech, Paris,
France), according to the manufacturer’s instructions. Isolated
CD14þ monocytes (purity of 98%) were cultured in AIM-V serum-
free medium (Life Technology, Invitrogen SARL, Cergy Pontoise,
France) at a concentration of 1 106 cellsml1 at 37 1C in a
humidified 5% CO2 environment. Monocytes were left in culture
before stimulation with either SEB (1–1,000 ngml1; Sigma-Aldrich,
L’isle d’Abeau Chenes, St Quentin Fallavier, France) or high pure
LPS (1–1,000ngml1; InvivoGen, Cayla-invivogen Europe, Tou-
louse, France) for 24 hours. Alternatively, highly purified SEB was
used as described (a gift from KR Acharya) (Mandron et al., 2006).
Cells were harvested for analysis of surface protein expression by
cytofluorometric analysis, and supernatants were collected and
stored at 20 1C for subsequent cytokines analysis.
Phenotypic analysis of monocytes
After 24 hours of simulation, monocytes were harvested and washed
with phosphate-buffered saline–bovine serum albumin (5%) and
10mM EDTA. Then, they were incubated for 20minutes with various
fluorescent mAbs in phosphate-buffered saline–bovine serum albu-
min, washed in phosphate-buffered saline, and analyzed by flow
cytometry using a Coulter Epics. Conjugated mAbs were as follows:
FITC-anti-CD14 (RMO52) and FITC-anti-HLA-DR (B8-12-2) from
Beckman-Coulter Immunotech (BC France SAS, Villepinte, France)
PE-anti-CD54 (HA58), FITC-anti-TLR2 (TL2.1), and PE-anti-TLR4
(HTA125) from eBioscience (Clinisciences SA Montrouge, France)
anti-TCR-PE (Miltenyi), and anti-CD56-PE (Beckman-Coulter Immu-
notech) to assess the presence of T cells and NK (natural killer) cells
in monocytes preparations. Contamination never exceeded 1% for T
cells and was less than 1% for NK cells.
Alternatively, CD14 sorted cells were incubated with increasing
concentrations of recombinant IFN-g (Roche, Neuilly sur Seine,
France) as indicated and analyzed for HLA-DR expression by flow
cytometry.
Analysis of cytokine secretion
Monocytes (1 106 cellsml1) were stimulated for 24 hours with
10 ngml1 of LPS or SEB. Concentrations of cytokines in the culture
supernatant were measured, as indicated, either by ELISA (Ready set
Go, eBioscience) or by using Cytometric Bead Array (BD
Biosciences, BD, Z.I des iles, Le Pont de Claix, France) according
to the manufacturer’s instructions. Acquisition was performed on
FACS Calibur (BD Biosciences). T cells and NK cells were purified
by using anti-TCR- and anti-CD56-coated beads, respectively,
according to Miltenyi Biotech’s instructions. Cells were treated with
SEB for 24 hours and cytokines (IFN-g, TNF-a) measured by ELISA as
indicated. Alternatively, purified monocytes were cocultured at
various cell ratio with autologous purified T cells as indicated,
coculture stimulated with SEB for 24 hours and cytokines (IFN-g,
TNF-a) measured by ELISA as indicated.
Neutralization assays
One hour before addition of SEB or LPS (10 ngml1), monocytes
were incubated for 30minutes at room temperature with 20 mgml1
of TLR2 neutralizing antibody (TL2.1 eBioscience) or 30minutes at
37 1C with 20 mgml1 anti-TLR4 antibody (HTA125, eBioscience).
Alternatively, a mixture of both anti-TLR was used as well as with
anti-MHC class II antibodies (at 10 mgml1; clone L243, BioLegend,
Ozyme, St Quentin en Yvelines, France). After 24 hours of
incubation, supernatants were collected and TNF-a secretion was
measured using a human TNF-a Ready set Go ELISA kit
(eBioscience), according to the manufacturer’s instructions.
Statistical analysis
Mean values were compared by using the Student’s t-test. All tests
were considered significant for Po0.01.
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